Ignite Creation Date:
2025-12-25 @ 5:05 AM
Ignite Modification Date:
2026-05-26 @ 6:11 AM
Study NCT ID:
NCT07001618
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-07-23
First Post:
2025-05-23
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Oral Pooled Fecal Microbiotherapy (MaaT033) Concomitant to Cemiplimab Versus Best Investigator's Choice in Patients With Resistance to Treatment Due to Antibiotics Uptake With Advanced Non-small Cell Lung Cancer
Sponsor:
Gustave Roussy, Cancer Campus, Grand Paris
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2024-517018-14-00
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None